Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 11, 2010
Refractory antineutrophil cytoplasmic antibody-associated vasculitis successfully treated with rituximab: a case reportYoshiro Horai, Tomoya Miyamura, Soichiro Takahama, et al.
HIV Medicine|August 9, 2025
Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamicsEisuke Adachi, Rumi Minami, Michinori Shirano, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 2, 2011
[Simultaneous relapse of Basedow's disease in a patient with adult-onset Still's disease]Masataka Torigoe, Tomoya Miyamura, Masataka Nakamura, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|April 28, 2016
Clinical study of giant cell arteritis in our hospitalEiichi Suematsu, Tomoya Miyamura, Masataka Nakamura, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 2, 2013
[Rapidly progressive pulmonary arterial hypertension associated with systemic sclerosis : a case report]Motoko Ishida, Tomoya Miyamura, Tomoe Kaieda, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 22, 2010
Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosusYoshiro Horai, Hideyuki Watanabe, Tomoya Miyamura, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|March 20, 2012
A case of refractory adult-onset Still's disease with high serum interleukin-18 levels treated with monitoring of serum levels of cyclosporineYoshiro Horai, Atsuko Koyama, Tomoya Miyamura, et al.
Internal Medicine (Tokyo, Japan)|May 6, 2026
A Fatal Case of AIDS Complicated by Kaposi's Sarcoma-associated Inflammatory Cytokine Syndrome (KICS)Tomohiro Tanaka, Masaki Tominaga, Kenji Tsumura, et al.
Plos One|January 8, 2025
Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohortYoshiyuki Yokomaku, Katsuji Teruya, Dai Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 4, 2026
Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohortDai Watanabe, Katsuji Teruya, Yoshiyuki Yokomaku, et al.
Pageof 6